New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.
From artificial intelligence to fatalities from music streaming to the effects of immigrants on elderly health care, the ...
FDA granted a narrow indication for CFD-FOLR1, targeting impaired folate transport into the CNS that drives developmental delay, seizures, movement disorders, and autistic features in some patients.
Tycoon2FA has become a leading phishing-as-a-service (PhaaS) platforms, enabling campaigns that reach over 500,000 organizations monthly, prompting Microsoft’s Digital Crimes Unit (DCU) to work with ...
Physical exertion combined with deep concentration can severely slow down human reaction times. A recent trial reveals that ...
Some regulators believe that there should be an outright ban on AI giving out mental health advice. A gotcha is that people already rely on AI. An AI Insider analysis.
Diet plays a big role in colon cancer prevention and regularly choosing certain foods, like cruciferous vegetables, may help ...
Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...
A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
Morning Overview on MSN
Tubulin may be a hidden shield against Alzheimer’s and Parkinson’s
A structural protein best known for building the internal scaffolding of cells may double as a natural defense against the ...
Jay Olson Oppenheimer & Co. Inc., Research Division. Hello, everyone, and welcome to Oppenheimer's 36th Annual Life Science Conference. I'm Jay Olson, one of the biotech analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results